Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (35)
  • 2024 (87)
  • 2023 (107)
  • 2022 (88)
  • 2021 (70)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (3855)
  • Synthetic drugs (1012)
  • Guns/Weapons (947)
  • OCDETF/Task Force (772)
  • Fake Pills (607)
  • Arrests/Convictions - Major (570)
  • Guilty Plea (503)
  • Seizures (Drugs/Property) (433)
  • Overdose (308)
  • Major Law Enforcement Operation (254)
  • Diversion Division (232)
  • Task Forces/Task Force Officers (225)
  • Pharmaceuticals/Pharmacists/Physicians (218)
  • Take Back Day (218)
  • Money Laundering (194)
  • Gangs (190)
  • Outreach/Drug Prevention (151)
  • Fentanyl Awareness (136)
  • HIDTA (98)
  • Press Conferences (67)
  • Prevention/Education - DEA websites GSAD, JTT etc (48)
  • Public and Media Affairs - also see Congressional Affairs (48)
  • Extraditions (47)
  • Narcoterrorism (47)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (27)
  • International/Foreign Operations (27)
  • Red Ribbon (26)
  • Congressional Affairs (15)
  • Terrorism (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Other (1)
  • Prescription Drugs (336)
  • One Pill Can Kill (97)

Drug Name

  • Fentanyl (116)
  • Oxycodone (75)
  • Opioids (62)
  • Synthetic Opioids (27)
  • Methamphetamine (21)
  • Hydromorphone (18)
  • Benzodiazepines (13)
  • Cocaine (12)
  • Morphine (10)
  • Heroin (9)
  • Amphetamines (8)
  • Marijuana (Cannabis) (5)
  • Methadone (5)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (53)
  • St. Louis (40)
  • Houston (39)
  • New York (33)
  • New England (26)
  • Sede (25)
  • Seattle (23)
  • Atlanta (22)
  • Dallas (21)
  • Miami (20)
  • Omaha (19)
  • Chicago (18)
  • New Jersey (16)
  • Rocky Mountain (16)
  • El Paso (12)
  • Los Angeles (9)
  • San Francisco (9)
  • New Orleans (8)
  • Louisville (7)
  • Phoenix (6)
  • San Diego (5)
  • Detroit (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions

Junio 26, 2023
CONCORD, N.H. – CVS has agreed to pay $70,000 to resolve allegations that it violated the Controlled Substances Act at CVS stores in New Hampshire, U.S. Attorney Jane E. Young announces. “Pharmacies have a legal responsibility to ensure that controlled substances are dispensed only pursuant to valid prescriptions,” said United...
Junio 26, 2023
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

Junio 23, 2023
WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
Junio 23, 2023
PRESS RELEASE

Jury Convicts Pain Clinic Doctor of Unlawful Drug Distribution, Money Laundering, and Filing a False Tax Return

Junio 23, 2023
TAMPA , F la. – United States Attorney Roger B. Handberg announced that a federal jury found Dr. Qing McGaha guilty of 14 counts of unlawful drug distribution, four (4) counts of money laundering, and one (1) count of filing a false tax return. McGaha faces a maximum penalty of...
Junio 23, 2023
PRESS RELEASE

San Jose Doctor Convicted of Twelve Counts of Illegally Prescribing Opioids

Junio 22, 2023
SAN JOSE, Calif. – A federal jury yesterday convicted family medicine physician Donald Siao of twelve counts of distributing the controlled substances Oxycodone and Hydrocodone outside the scope of his usual professional practice and without a legitimate medical purpose, announced United States Attorney Ismail J. Ramsey, Drug Enforcement Administration (DEA)...
Junio 22, 2023
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

Junio 22, 2023
ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
Junio 22, 2023
PRESS RELEASE

Federal and State Law Enforcement Warn of Increased Threats Related to Fentanyl

Junio 22, 2023
DENVER - An influx of substances, more potent and deadlier than ever, are being seized in Colorado in record amounts. Fentanyl pills in all colors, shapes and sizes; fentanyl in liquid and powder form; and fentanyl adulterated with Xylazine are leading to an increased number of drug poisonings and overdoses...
Junio 22, 2023
PRESS RELEASE

Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths

Junio 16, 2023
ANCHORAGE, ALASKA—Former Advanced Nurse Practitioner Jessica Joyce Spayd (52) was sentenced in U.S. District Court yesterday to 30 years (360 months) imprisonment for illegally prescribing and dispensing opioids outside the scope of legitimate medical practice that resulted in the deaths of five people between 2014 and 2019. United States District...
Junio 16, 2023
PRESS RELEASE

Jamestown Man Pleads Guilty to Drug Conspiracy

Junio 14, 2023
ROCHESTER, N.Y.-U.S. Attorney Trini E. Ross announced today that Richard A. Philbrick, 37, of Jamestown, NY, pleaded guilty before U.S. District Judge Lawrence J. Vilardo to conspiracy to possess with intent to distribute, and to distribute, 400 grams or more fentanyl. The charges carry a mandatory minimum penalty of 10...
Junio 14, 2023
PRESS RELEASE

Pocatello Nurse Practitioner is Fined and Surrenders License for Unlawful Prescriptions and Fraud

Junio 14, 2023
BOISE – Rachel Peay-Goodman, a nurse practitioner in eastern Idaho, consented to judgment against her after admitting that she unlawfully prescribed controlled substances and submitted false claims to Medicare while working for AmeriHealth in Pocatello, announced U.S. Attorney Josh Hurwit. The judgment found Peay‑Goodman civilly liable for violating the Controlled...
Junio 14, 2023
PRESS RELEASE

Dealer of Fake Oxycodone Sentenced to 20 Years in Federal Prison for Fentanyl Death

Junio 01, 2023
AUSTIN, Texas – A Cedar Park man was sentenced in a federal court in Austin last Friday to 20 years in prison for distribution of fentanyl causing death. According to court documents, Jean Claude Meama-Kajue, 29, sold counterfeit Oxycodone containing fentanyl to a male subject in December 2020, coordinating the...
Junio 01, 2023
Showing 181 - 190 of 430 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Current page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español